MeiraGTx Holdings plc ( MGTX) - Key Metrics
MGTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.52 | $1.76 | -$0.42 | -$0.40 |
| 2026Q1 | $0 | -$0.57 | $0.22 | $0.19 |
| 2025Q4 | $0.93 | $0.19 | $0.57 | $0.49 |
| 2025Q3 | $0.01 | -$0.62 | -$0.15 | -$0.16 |
| 2025Q2 | $0.05 | -$0.48 | -$0.55 | -$0.56 |
MGTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 1.92 |
| 2026Q1 | 0% | -3.80 |
| 2025Q4 | 0% | 10.46 |
| 2025Q3 | 0% | -3.32 |
| 2025Q2 | 0% | -3.40 |
MGTX
Price: $9.28
52 week price:
Earnings Per Share: 0.87 USD
P/E Ratio: 15.97
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 226305
Market Capitalization: 1.0 billion